Recent Advances in Nanodrug Delivery Systems Production, Efficacy, Safety, and Toxicity
- PMID: 39312172
- DOI: 10.1007/978-1-0716-4003-6_15
Recent Advances in Nanodrug Delivery Systems Production, Efficacy, Safety, and Toxicity
Abstract
In the last three decades, the development of nanoparticles or nano-formulations as drug delivery systems has emerged as a promising tool to overcome the limitations of conventional delivery, potentially to improve the stability and solubility of active molecules, promote their transport across the biological membranes, and prolong circulation times to increase efficacy of a therapy. Despite several nano-formulations having applications in drug delivery, some issues concerning their safety and toxicity are still debated. This chapter describes the recent available information regarding safety, toxicity, and efficacy of nano-formulations for drug delivery. Several key factors can influence the behavior of nanoparticles in a biological environment, and their evaluation is crucial to design non-toxic and effective nano-formulations. Among them, we have focused our attention on materials and methods for their preparation (including the innovative microfluidic technique), mechanisms of interactions with biological systems, purification of nanoparticles, manufacture impurities, and nano-stability. This chapter places emphasis on the utilization of in silico, in vitro, and in vivo models for the assessment and prediction of toxicity associated with these nano-formulations. Furthermore, the chapter includes specific examples of in vitro and in vivo studies conducted on nanoparticles, illustrating their application in this field.
Keywords: Biomimetics; Drug delivery; Efficacy; Hybrids; Microfluidics; Nano-formulation; Nanoparticle; Nanotechnology; Nanotoxicity; Polymer; Safety; Toxicity; mRNA vaccines.
© 2025. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Nanoformulations for Drug Delivery: Safety, Toxicity, and Efficacy.Methods Mol Biol. 2018;1800:347-365. doi: 10.1007/978-1-4939-7899-1_17. Methods Mol Biol. 2018. PMID: 29934902
-
Nano-Drug Delivery Systems Based on Natural Products.Int J Nanomedicine. 2024 Jan 18;19:541-569. doi: 10.2147/IJN.S443692. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38260243 Free PMC article. Review.
-
Resveratrol-loaded nanomedicines for cancer applications.Cancer Rep (Hoboken). 2021 Jun;4(3):e1353. doi: 10.1002/cnr2.1353. Epub 2021 Mar 2. Cancer Rep (Hoboken). 2021. PMID: 33655717 Free PMC article. Review.
-
The nano delivery systems and applications of mRNA.Eur J Med Chem. 2022 Jan 5;227:113910. doi: 10.1016/j.ejmech.2021.113910. Epub 2021 Oct 8. Eur J Med Chem. 2022. PMID: 34689071 Free PMC article. Review.
-
Nano delivery system for paclitaxel: Recent advances in cancer theranostics.Colloids Surf B Biointerfaces. 2023 Aug;228:113419. doi: 10.1016/j.colsurfb.2023.113419. Epub 2023 Jun 22. Colloids Surf B Biointerfaces. 2023. PMID: 37393700 Review.
Cited by
-
Advancements in Nanomedicine for the Diagnosis and Treatment of Kidney Stones.Int J Nanomedicine. 2025 Feb 3;20:1401-1423. doi: 10.2147/IJN.S504318. eCollection 2025. Int J Nanomedicine. 2025. PMID: 39925679 Free PMC article. Review.
-
Targeting Drp1 in Cerebral Ischemia-Reperfusion Injury: Mechanisms and Therapeutic Implications.CNS Neurosci Ther. 2025 Aug;31(8):e70590. doi: 10.1111/cns.70590. CNS Neurosci Ther. 2025. PMID: 40878129 Free PMC article. Review.
-
Gold Nanoparticles as Targeted Drug Delivery Systems for Liver Cancer: A Systematic Review of Tumor Targeting Efficiency and Toxicity Profiles.Int J Mol Sci. 2025 Aug 16;26(16):7917. doi: 10.3390/ijms26167917. Int J Mol Sci. 2025. PMID: 40869246 Free PMC article. Review.
References
-
- Lopalco A, Denora N (2018) Nanoformulations for drug delivery: safety, toxicity, and efficacy. Methods Mol Biol 1800:347–365. https://doi.org/10.1007/978-1-4939-7899-1_17 - DOI - PubMed
-
- Bawa R (2015) Nanopharmaceuticals for drug delivery – a review. Eur J Nanomedicine:122–127. https://doi.org/10.1002/9781394167708.ch2
-
- Weissig V, Pettinger TK, Murdock N (2014) Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine:4357–4373. https://doi.org/10.2147/IJN.S46900
-
- De Jong WH, Borm PJA (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3:133–149. https://doi.org/10.2147/ijn.s596 - DOI - PubMed - PMC
-
- Ailuno G, Iacobazzi RM, Lopalco A et al (2021) The pharmaceutical technology approach on imaging innovations from Italian research. Pharmaceutics 13:1214. https://doi.org/10.3390/pharmaceutics13081214 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources